Blood Tests

Launching a new era of chronic disease
management with the world’s first blood
biomarker-based remote monitoring
solution for cardio-renal disease.

  • Healthcare Professionals

    Find out how GPx can help monitor your Heart Failure (HF) and Pulmonary Arterial Hypertension patients better.

  • Life Sciences Companies

    Find out how partnering with GPx can accelerate clinical trials and collection of real-world evidence.


A bloodless future for healthcare?

Blood tests are the gold standard for predicting disease progression. Unfortunately, blood tests may also be time consuming, expensive, and painful. What if your smartwatch could tell you when vital blood biomarkers change?
A bloodless future for healthcare

Our Purpose

GPx is enhancing remote patient management by building a new class of biomarkers called Bloodless Blood Tests. Through our AI-powered Canary Prediction Engine, digital biomarkers collected from patient wearables and peripherals transform into an unparalleled window into patient blood biomarker status. With this data, physicians benefit from presymptomatic detection of critical patient condition changes, enabling timely treatment that avoids hospital readmissions.
Our Purpose

Our News

Find out the latest on GPx

Join #GPx co-founders Javier Echenique and @seanmatsuoka in San Diego on Sept. 8-10th for #HeartRhythmSociety's #HRX2022.

Check out the video from Javier to learn more:


GPx is proud to announce that Jim Yearick has joined the company’s strategic advisory board. Jim is currently the Senior VP of sales and marketing at Endotronix, which is quickly improving the remote monitoring of heart failure patients. He brings over 30 years of medical device

Our Partners

  • KU Medical Center
  • Duke Health
  • Medical Universiyt of Vienna
  • Narayana Health
  • Hospital Univarsitario

Contact us

Let us know about your remote blood biomarker monitoring needs.